Aim: For the problem of the struggle of the human body with extreme strains, it is advisable to use activepharmaceutical ingredients that would directly participate in the metabolism having an actoprotective effectwithout exhausting the body. Levocarnitine and glucosamine have such properties. In this work was studiedthe development of the pharmaceutical market of Ukraine and the definition of market needs for combined andmonopreparations of levocarnitine and glucosamine. Materials and Methods: The analysis of the market fromJanuary 2015 to September 2017 showed a significant increase in the sales of glucosamine hydrochloride andlevocarnitine products, both in natural and monetary equivalents. Thus, the analysis of the data proves that theanabolic and frigoprotective properties of glucosamine have not received enough attention. The statistical datasuggest that there is a growing market demand for levocarnitine for oral administration. Results: The ratio of thesales of glucosamine hydrochloride for injections and for oral use began to change when one of the Ukrainiandrug manufacturers came out on the market with generic glucosamine hydrochloride for oral use. The changesin the price of one dose of glucosamine hydrochloride for oral use are due to the growth of the market shareoccupied by Ukrainian producers in this segment too. Such a shift in sales toward Ukrainian drugs contributes tothe overall increase in the availability of drugs. Conclusions: Analysis of Ukrainian market of the glucosamineand levocarnitine preparations showed uneven distribution of foreign and domestic manufacturers.